免疫细胞调控颌骨稳态及损伤修复的研究进展

doi:10.13591/j.cnki.kqyx.2023.05.014

摘要/Abstract

摘要：

颌骨在生命周期中不断地更新重塑,是口颌系统的关键部分。颌骨的稳态和损伤修复受到多种细胞、分子调控。其中,免疫细胞发挥着重要的调控作用。大量研究已证实,免疫系统可以通过多种直接、间接途径调控骨稳态和重塑过程。本文针对免疫细胞调控颌骨稳态和修复的机制进行综述,以期为后续的深入研究提供思路。

关键词: 颌骨稳态, 颌骨重建, 骨免疫, 成骨细胞, 破骨细胞

Abstract:

The jaw is constantly renewed and remodeled throughout the lifetime and is a crucial part of the stomatognathic system. The jaw homeostasis and repair of jaw injury are regulated by multiple cells and molecules, in which immune cells play an important role. Numerous studies have confirmed that the immune system could regulate the process of bone homeostasis and bone remodeling by direct and indirect pathways. This review summarizes the mechanisms of immune cells regulating bone homeostasis and bone reconstruction in order to provide ideas for future in-depth research.

Key words: jaw homeostasis, jaw reconstruction, bone immunity, osteoblast, osteoclast

中图分类号:

R782.23

钟嘉伟,潘剑,郭雨晨. 免疫细胞调控颌骨稳态及损伤修复的研究进展[J]. 口腔医学, 2023, 43(5): 465-470.

ZHONG Jiawei,PAN Jian,GUO Yuchen. Advances in the regulation of immune cells in jaw homeostasis and damage repair[J]. Stomatology, 2023, 43(5): 465-470.

参考文献 80

[1]	Peres MA, MacPherson LMD, Weyant RJ, et al. Oral diseases: A global public health challenge[J]. Lancet, 2019, 394(10194):249-260. doi: S0140-6736(19)31146-8 pmid: 31327369
[2]	Thrivikraman G, Athirasala A, Twohig C, et al. Biomaterials for craniofacial bone regeneration[J]. Dent Clin North Am, 2017, 61(4):835-856. doi: S0011-8532(17)30069-1 pmid: 28886771
[3]	Dar HY, Azam Z, Anupam R, et al. Osteoimmunology: The Nexus between bone and immune system[J]. Front Biosci (Landmark Ed), 2018, 23(3):464-492. doi: 10.2741/4600
[4]	Arron JR, Choi Y. Bone versus immune system[J]. Nature, 2000, 408(6812):535-536. doi: 10.1038/35046196
[5]	Yoshida H, Hayashi S, Kunisada T, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene[J]. Nature, 1990, 345(6274):442-444. doi: 10.1038/345442a0
[6]	Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW Jr, et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse[J]. Proc Natl Acad Sci USA, 1990, 87(12):4828-4832. doi: 10.1073/pnas.87.12.4828 pmid: 2191302
[7]	Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation[J]. Cell, 1998, 93(2):165-176. doi: 10.1016/s0092-8674(00)81569-x pmid: 9568710
[8]	雷雨田. 脉冲电磁场调节Akt/mTOR信号通路抑制RAW264.7巨噬细胞向破骨细胞分化[D]. 广州: 南方医科大学, 2018.
[9]	Weitzmann MN, Vikulina T, Roser-Page S, et al. Homeostatic expansion of CD4⁺ T cells promotes cortical and trabecular bone loss, whereas CD8⁺ T cells induce trabecular bone loss only[J]. J Infect Dis, 2017, 216(9):1070-1079. doi: 10.1093/infdis/jix444 pmid: 28968828
[10]	González-Osuna L, Sierra-Cristancho A, Rojas C, et al. Premature senescence of T-cells favors bone loss during osteolytic diseases. A new concern in the osteoimmunologyarena[J]. Aging Dis, 2021, 12(5):1150-1161. doi: 10.14336/AD.2021.0110
[11]	Deng ZQ, Zhang Q, Zhao Z, et al. Crosstalk between immune cells and bone cells or chondrocytes[J]. Int Immunopharmacol, 2021, 101(Pt A):108179. doi: 10.1016/j.intimp.2021.108179
[12]	Liu HR, Luo TT, Tan JL, et al. ‘osteoimmunology’ offers new perspectives for the treatment of pathological bone loss[J]. Curr Pharm Des, 2017, 23(41):6272-6278. doi: 10.2174/1381612823666170511124459
[13]	Weitzmann MN. Bone and the immune system[J]. Toxicol Pathol, 2017, 45(7):911-924. doi: 10.1177/0192623317735316 pmid: 29046115
[14]	Takayanagi H, Ogasawara K, Hida S, et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma[J]. Nature, 2000, 408(6812):600-605. doi: 10.1038/35046102
[15]	AyonHaro ER, Ukai T, Yokoyama M, et al. Locally administered interferon-γ accelerates lipopolysaccharide-induced osteoclastogenesis independent of immunohistological RANKL upregulation[J]. J Periodontal Res, 2011, 46(3):361-373. doi: 10.1111/j.1600-0765.2011.01352.x pmid: 21361961
[16]	Biros E, Malabu UH, Vangaveti VN, et al. The IFN-γ/miniTrpRS signaling axis: An insight into the pathophysiology of osteoporosis and therapeutic potential[J]. Cytokine Growth Factor Rev, 2022, 64: 7-11. doi: 10.1016/j.cytogfr.2022.01.005
[17]	Sato K, Suematsu A, Okamoto K, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction[J]. J Exp Med, 2006, 203(12):2673-2682. doi: 10.1084/jem.20061775 pmid: 17088434
[18]	Chen Z, Bozec A, Ramming A, et al. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis[J]. Nat Rev Rheumatol, 2019, 15(1):9-17. doi: 10.1038/s41584-018-0109-2 pmid: 30341437
[19]	Schinocca C, Rizzo C, Fasano S, et al. Role of the IL-23/IL-17 pathway in rheumatic diseases: An overview[J]. Front Immunol, 2021, 12: 637829. doi: 10.3389/fimmu.2021.637829
[20]	Maeda K, Yoshida K, Nishizawa T, et al. Inflammation and bone metabolism in rheumatoid arthritis: Molecular mechanisms of joint destruction and pharmacological treatments[J]. Int J MolSci, 2022, 23(5):2871.
[21]	Croes M, Öner FC, van Neerven D, et al. Proinflammatory T cells and IL-17 stimulate osteoblast differentiation[J]. Bone, 2016, 84: 262-270. doi: S8756-3282(16)00011-9 pmid: 26780388
[22]	Croes M, Kruyt MC, Groen WM, et al. Interleukin 17 enhances bone morphogenetic protein-2-induced ectopic bone formation[J]. Sci Rep, 2018, 8(1):7269. doi: 10.1038/s41598-018-25564-9 pmid: 29740080
[23]	Zhang WJ, Dang K, Huai Y, et al. Osteoimmunology: the regulatory roles of T lymphocytes in osteoporosis[J]. Front Endocrinol (Lausanne), 2020, 11: 465. doi: 10.3389/fendo.2020.00465
[24]	Li Y, Toraldo G, Li AM, et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo[J]. Blood, 2007, 109(9):3839-3848. doi: 10.1182/blood-2006-07-037994
[25]	Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems[J]. Nat Rev Immunol, 2007, 7(4):292-304. doi: 10.1038/nri2062 pmid: 17380158
[26]	Hathaway-Schrader JD, Novince CM. Maintaining homeostatic control of periodontal bone tissue[J]. Periodontol 2000, 2021, 86(1):157-187. doi: 10.1111/prd.v86.1
[27]	Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerinligand[J]. Nature, 1999, 402(6759):304-309. doi: 10.1038/46303
[28]	Nakane S, Imamura K, Hisanaga R, et al. Systemic administration of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)-Ig abrogates alveolar bone resorption in induced periodontitis through inhibition of osteoclast differentiation and activation: An experimental investigation[J]. J Periodontal Res, 2021, 56(5):972-981. doi: 10.1111/jre.v56.5
[29]	Komatsu N, Takayanagi H. Mechanisms of joint destruction in rheumatoid arthritis-immune cell-fibroblast-bone interactions[J]. Nat Rev Rheumatol, 2022, 18(7):415-429. doi: 10.1038/s41584-022-00793-5 pmid: 35705856
[30]	Li XY, Xu HH, Huang J, et al. Dysfunctions, molecular mechanisms, and therapeutic strategies of regulatory T cells in rheumatoid arthritis[J]. Front Pharmacol, 2021, 12: 716081. doi: 10.3389/fphar.2021.716081
[31]	Bozec A, Zaiss MM. T regulatory cells in bone remodelling[J]. CurrOsteoporos Rep, 2017, 15(3):121-125.
[32]	Zhang W, Zhao W, Li W, et al. The imbalance of cytokines and lower levels of tregs in elderly male primary osteoporosis[J]. Front Endocrinol (Lausanne), 2022, 13: 779264. doi: 10.3389/fendo.2022.779264
[33]	Fischer L, Herkner C, Kitte R, et al. Foxp3⁺ regulatory T cells in bone and hematopoietic homeostasis[J]. Front Endocrinol (Lausanne), 2019, 10: 578. doi: 10.3389/fendo.2019.00578
[34]	Liu Y, Wang L, Kikuiri T, et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-Α[J]. Nat Med, 2011, 17(12):1594-1601. doi: 10.1038/nm.2542 pmid: 22101767
[35]	Greene AC, Shehabeldin M, Gao J, et al. Local induction of regulatory T cells prevents inflammatory bone loss in ligature-induced experimental periodontitis in mice[J]. Sci Rep, 2022, 12(1):5032. doi: 10.1038/s41598-022-09150-8 pmid: 35322204
[36]	Fan X, Chi GH, Yan L, et al. Treg-promoted new bone formation through suppressing TH17 by secreting interleukin-10 in ankylosing spondylitis[J]. Spine, 2019, 44(23):E1349-E1355. doi: 10.1097/BRS.0000000000003169
[37]	Li J, Yu TT, Yan HC, et al. T cells participate in bone remodeling during the rapid palatal expansion[J]. FASEB J, 2020, 34(11):15327-15337. doi: 10.1096/fsb2.v34.11
[38]	Alvarez C, Suliman S, Almarhoumi R, et al. Regulatory T cell phenotype and anti-osteoclastogenic function in experimental periodontitis[J]. Sci Rep, 2020, 10(1):19018. doi: 10.1038/s41598-020-76038-w pmid: 33149125
[39]	Komatsu N, Okamoto K, Sawa S, et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis[J]. Nat Med, 2014, 20(1):62-68. doi: 10.1038/nm.3432 pmid: 24362934
[40]	Wang YN, Liu SY, Jia TT, et al. T cell protein tyrosine phosphatase in osteoimmunology[J]. Front Immunol, 2021, 12: 620333. doi: 10.3389/fimmu.2021.620333
[41]	Sun W, Meednu N, Rosenberg A, et al. B cells inhibit bone formation in rheumatoid arthritis by suppressing osteoblast differentiation[J]. Nat Commun, 2018, 9(1):5127. doi: 10.1038/s41467-018-07626-8 pmid: 30510188
[42]	Han YK, Jin Y, Miao YB, et al. Improved RANKL expression and osteoclastogenesis induction of CD27⁺CD38^-memory B cells: A link between B cells and alveolar bone damage in periodontitis[J]. J Periodontal Res, 2019, 54(1):73-80. doi: 10.1111/jre.2019.54.issue-1
[43]	Deshet-Unger N, Kolomansky A, Ben-Califa N, et al. Erythropoietin receptor in B cells plays a role in bone remodeling in mice[J]. Theranostics, 2020, 10(19):8744-8756. doi: 10.7150/thno.45845 pmid: 32754275
[44]	Pereira M, Petretto E, Gordon S, et al. Common signalling pathways in macrophage and osteoclast multinucleation[J]. J Cell Sci, 2018, 131(11):jcs216267. doi: 10.1242/jcs.216267
[45]	Yang DH, Yang MY. The role of macrophage in the pathogenesis of osteoporosis[J]. Int J MolSci, 2019, 20(9):2093.
[46]	Zhao DW, Ren B, Wang HW, et al. 3D-printed titanium implant combined with interleukin 4 regulates ordered macrophage polarization to promote bone regeneration and angiogenesis[J]. Bone Joint Res, 2021, 10(7):411-424. doi: 10.1302/2046-3758.107.BJR-2020-0334.R4
[47]	Trout KL, Holian A. Factors influencing multinucleated giant cell formationin vitro[J]. Immunobiology, 2019, 224(6):834-842. doi: 10.1016/j.imbio.2019.08.002
[48]	Dou C, Ding N, Zhao CR, et al. Estrogen deficiency-mediated M2 macrophage osteoclastogenesis contributes to M1/M2 ratio alteration in ovariectomized osteoporotic mice[J]. J Bone Miner Res, 2018, 33(5):899-908. doi: 10.1002/jbmr.3364 pmid: 29281118
[49]	Srivastava RK, Dar HY, Mishra PK. Immunoporosis: Immunology of osteoporosis-role of T cells[J]. Front Immunol, 2018, 9: 657. doi: 10.3389/fimmu.2018.00657 pmid: 29675022
[50]	Jung YK, Kang YM, Han S. Osteoclasts in the inflammatory arthritis: Implications for pathologic osteolysis[J]. Immune Netw, 2019, 19(1):e2. doi: 10.4110/in.2019.19.e2
[51]	Kaplanski G. Interleukin-18: Biologicalproperties and role in disease pathogenesis[J]. Immunol Rev, 2018, 281(1):138-153. doi: 10.1111/imr.12616 pmid: 29247988
[52]	Yasuda K, Nakanishi K, Tsutsui H. Interleukin-18 in health and disease[J]. Int J MolSci, 2019, 20(3):649.
[53]	Tao ZB, Wang JP, Wen KC, et al. Pyroptosis in osteoblasts: A novel hypothesis underlying the pathogenesis of osteoporosis[J]. Front Endocrinol (Lausanne), 2021, 11: 548812. doi: 10.3389/fendo.2020.548812
[54]	Ni FF, Zhang T, Xiao WN, et al. IL-18-mediated SLC7A5 overexpression enhances osteogenic differentiation of human bone marrow mesenchymal stem cells via the c-MYC pathway[J]. Front Cell DevBiol, 2021, 9: 748831.
[55]	Harmer D, Falank C, Reagan MR. Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma[J]. Front Endocrinol, 2019, 9: 788. doi: 10.3389/fendo.2018.00788
[56]	Han L, Chen Z, Yu K, et al. Interleukin 27 signaling in rheumatoid arthritis patients: Good or evil?[J]. Front Immunol, 2022, 12: 787252. doi: 10.3389/fimmu.2021.787252
[57]	Li XH, Luo W, Hu JX, et al. Interleukin-27 prevents LPS-induced inflammatory osteolysis by inhibiting osteoclast formation and function[J]. Am J Transl Res, 2019, 11(3):1154-1169. pmid: 30972153
[58]	Pajarinen J, Lin T, Gibon E, et al. Mesenchymal stem cell-macrophage crosstalk and bone healing[J]. Biomaterials, 2019, 196: 80-89. doi: S0142-9612(17)30834-7 pmid: 29329642
[59]	Sinder BP, Pettit AR, McCauley LK. Macrophages: their emerging roles in bone[J]. J Bone Miner Res, 2015, 30(12):2140-2149. doi: 10.1002/jbmr.2735 pmid: 26531055
[60]	Huang J, Zhou Y, Wang Y, et al. The mutual effects between macrophages and cartilage templates in the process of subcutaneous endochondral bone formation[J]. RSC Adv, 2018, 8(42):23679-23687. doi: 10.1039/c8ra04463e pmid: 35540265
[61]	Michalski MN, McCauley LK. Macrophages and skeletal health[J]. Pharmacol Ther, 2017, 174: 43-54. doi: 10.1016/j.pharmthera.2017.02.017
[62]	Raggatt LJ, Wullschleger ME, Alexander KA, et al. Fracture healing via periosteal callus formation requires macrophages for both initiation and progression of early endochondralossification[J]. Am J Pathol, 2014, 184(12):3192-3204. doi: 10.1016/j.ajpath.2014.08.017 pmid: 25285719
[63]	Yang N, Liu Y. The role of the immune microenvironment in bone regeneration[J]. Int J Med Sci, 2021, 18(16):3697-3707. doi: 10.7150/ijms.61080 pmid: 34790042
[64]	Vi L, Baht GS, Whetstone H, et al. Macrophages promote osteoblastic differentiation in-vivo: Implications in fracture repair and bone homeostasis[J]. J Bone Miner Res, 2015, 30(6):1090-1102. doi: 10.1002/jbmr.2422
[65]	Shukla P, Mansoori MN, Singh D. Efficacy of anti-IL-23 monotherapy versus combination therapy with anti-IL-17 in estrogen deficiency induced bone loss conditions[J]. Bone, 2018, 110: 84-95. doi: S8756-3282(18)30049-8 pmid: 29414600
[66]	Shukla P, Mansoori MN, Kakaji M, et al. Interleukin 27 (IL-27) alleviates bone loss in estrogen-deficient conditions by induction of early growth response-2 gene[J]. J BiolChem, 2017, 292(11):4686-4699.
[67]	Vi L, Baht GS, Soderblom EJ, et al. Macrophage cells secrete factors including LRP1 that orchestrate the rejuvenation of bone repair in mice[J]. Nat Commun, 2018, 9(1):5191. doi: 10.1038/s41467-018-07666-0 pmid: 30518764
[68]	Heymann D, Rousselle AV. gp130 Cytokine family and bone cells[J]. Cytokine, 2000, 12(10):1455-1468. pmid: 11023660
[69]	Feng XM, Shen SL, Cao PP, et al. The role of oncostatin M regulates osteoblastic differentiation of dental pulp stem cells through STAT3 pathway[J]. Cytotechnology, 2016, 68(6):2699-2709. pmid: 27376650
[70]	Wang JS, Zheng ZY, Huang B, et al. Osteal tissue macrophages are involved in endplate osteosclerosis through the OSM-STAT3/YAP1 signaling axis in modicchanges[J]. J Immunol, 2020, 205(4):968-980. doi: 10.4049/jimmunol.1901001
[71]	Cai BL, Lin D, Li Y, et al. N2-polarized neutrophils guide bone mesenchymal stem cell recruitment and initiate bone regeneration: A missing piece of the bone regeneration puzzle[J]. AdvSci (Weinh), 2021, 8(19):e2100584.
[72]	Zhao J, Zhao Q, Ning P, et al. G-CSF inhibits growths of osteoblasts and osteocytes by upregulating nitric oxide production in neutrophils[J]. J CraniofacSurg, 2019, 30(8):e776-e780.
[73]	Li CJ, Xiao Y, Sun YC, et al. Senescent immune cells release grancalcin to promote skeletal aging[J]. Cell Metab, 2021, 33(10):1957-1973.e6. doi: 10.1016/j.cmet.2021.08.009
[74]	Ng CW, Chan BCL, Ko CH, et al. Human mast cells induce osteoclastogenesis through cell surface RANKL[J]. Inflamm Res, 2022, 71(10/11):1261-1270. doi: 10.1007/s00011-022-01608-9
[75]	Kroner J, Kovtun A, Kemmler J, et al. Mast cells are critical regulators of bone fracture-induced inflammation and osteoclast formation and activity[J]. J Bone Miner Res, 2017, 32(12):2431-2444. doi: 10.1002/jbmr.3234 pmid: 28777474
[76]	Fischer V, Haffner-Luntzer M. Interaction between bone and immune cells: Implications for postmenopausal osteoporosis[J]. Semin Cell Dev Biol, 2022, 123: 14-21. doi: 10.1016/j.semcdb.2021.05.014
[77]	Zhang LZ, Wang T, Chang M, et al. Teriparatide treatment improves bone defect healing via anabolic effects on new bone formation and non-anabolic effects on inhibition of mast cells in a murine cranial window model[J]. J Bone Miner Res, 2017, 32(9):1870-1883. doi: 10.1002/jbmr.v32.9
[78]	Maximiano WMA, da Silva EZM, Santana AC, et al. Mast cell mediators inhibit osteoblastic differentiation and extracellular matrix mineralization[J]. J HistochemCytochem, 2017, 65(12):723-741.
[79]	Lind T, Melo FR, Gustafson AM, et al. Mast cell chymase has a negative impact on human osteoblasts[J]. Matrix Biol, 2022, 112: 1-19. doi: 10.1016/j.matbio.2022.07.005
[80]	Lin WM, Li QW, Zhang DT, et al. Mapping the immune microenvironment for mandibular alveolar bone homeostasis at single-cell resolution[J]. Bone Res, 2021, 9(1):17. doi: 10.1038/s41413-021-00141-5 pmid: 33723232